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Accepted 29 April 2011A 28-year-old pregnant woman presented with a pelvic
mass that was causing no discomfort. Gray-scale transvaginal
sonography revealed a 6-week intrauterine gestation, a 6-cm,
irregular, left-sided adnexal tumor, and a blurred interface
between the tumor and the uterus. Her serum cancer antigen
(CA) 125 level (Architect CA 125 II, CMIA, Abbott Labora-
tories, Abbott Park, IL, USA) was 1007 U/mL, but the levels of
carcinoembryonic antigen (CEA), carbohydrate antigen (CA)
199, and lactate dehydrogenase (LDH) were within normal
ranges.
On color mapping analysis, no central vascularity presented
in the mass, but tumor-feeding vessels from the uterus were
clear (Fig. 1A and 1B), thus leading to a diagnosis of subserosal
myoma. The Doppler waveform of one tumor-feeding artery
revealed a resistance index of 0.65 and a peak systolic velocity
of 40 cm/s. The mass grew continuously, up to 8 cm  8 cm 
9 cm in the third trimester. The CA 125 level was 421 U/mL at
7 weeks’ gestation and then quickly decreased to 66 U/mL at
the end of the first trimester, before further gradually falling to
44 U/mL at term.
During cesarean section for a breech presentation, endome-
triosis was not detected but an irregular reddish-white subserosal
myoma was noted and excised. This measured approximately
9 cm 9cm 8 cm and was connected to the left upper anterior
uterine wall via a 4 cm  2 cm stalk (Fig. 2). Microscopic
examination confirmed a myoma with hyaline degeneration and
hyaline necrosis.
Most patients with a subserosal myoma of the uterus are
asymptomatic, meaning that it often grows into a large pelvic
mass. In clinical practice, it is possible to misdiagnose
a complex degenerated subserosal myoma as an ovarian tumor
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results in an excessive emotional burden on the patient,
a waste of medical resources in terms of advanced imaging
studies, and a precipitate operation possibly conducted during
pregnancy.
CA 125 is expressed by amniotic, coelomic, and mu¨llerian
epithelia and is amarker for epithelial ovarian cancer, carcinoma
of the fallopian tube, and endometrial carcinoma.When CA 125
is used to screen for ovarian cancer, an abnormal level (> 35 U/
mL) is observed in only 50% of patients with stage I disease, and
a higher value carries a better positive predictive rate [2]. A high
CA 125 level is also likely to be associated with endometriosis,
adenomyosis, pelvic inflammatory disease, pleural effusion,
menstrual period, pregnancy, threatened abortion, and myoma
[2e7].
According to a recent review, the association of elevated
CA125 with myoma is inconsistent, and the rise of CA125 is
usually small [4]. In addition, there are only rare reports of
a high CA 125 level (>1000 U/mL) being detected in patients
with myoma [4]. In the report by Ghaemmaghami et al, one
patient (46 years of age) had an intramural myoma (7 cm 
5 cm in size) and the other (16 years old) presented with
multiple myomas together with a significant rise in CA 125
level measured during the menstrual period. In theory, perito-
neal irritation is likely provoked by a degenerated subserosal
myoma. However, the evidence in literature regarding the
association of a degenerated subserosal myoma with a very high
CA 125 level remains lacking.
In normal pregnancy, the CA 125 serum level increases [3,
5],up to 60%, during the first trimester, and then falls until term
[3].The higher CA 125 levels in early pregnancy are possibly
related to the process of trophoblast invasion of the decidua
during implantation [5]. However, a CA125 level above
1000 U/mL in early pregnancy has not been reported. The
synergic effects of trophoblastic invasion and the degeneration
of a subserosal myoma may in part explain our patient’s very
high CA 125 level in early pregnancy.cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. A pregnant woman, at 6 weeks’ gestation, presented with a CA 125 level of 1007 U/mL and a left pelvic mass. (A) Transverse view during transvaginal
sonography shows an intrauterine gestation (black arrow) and a blurred interface (white arrows) between the mass (M) and the uterus. (B) On color mapping,
identification of a connecting vessel (white arrow) between the mass (M) and the uterus (Ut), containing a gestational sac (black arrow), helps make a diagnosis of
subserosal myoma.
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cantly affected during pregnancy and remain as reliable tumor
markers in pregnancy [3]. CEA is associated with mucinous
ovarian carcinoma. A high CA 199 value is observed in patients
with gastrointestinal cancer, ovarian adenocarcinoma, endo-
metriosis, and dermoid cyst [8]. This case report indicates that
a very high serum CA 125 level, i.e. >1000 U/mL, detected
in early pregnancy may be associated with a degenerated sub-
serosal myoma, and sequential CA 125 levels could fall
significantly in the first trimester.
On gray-scale sonography, it may be difficult to identify or
confirm the connecting stalk of a large pedunculated sub-
serosal myoma. However, the identification of tumor-feeding
vessels from the uterus by color Doppler analysis certainly
plays a valuable role in differentiating a subserosal myoma
from an ovarian tumor, thus preventing an unnecessary lapa-
rotomy during early pregnancy. Further, an attempt to identify
bilateral normal ovaries is an alternative to exclude an ovarian
origin for the mass. Occasionally, bilateral ovaries may be
difficult to detect by sonography when they are displaced by
a huge tumor. The incidence of malignant change in a uterine
myoma is low, up to 0.27% [9].Fig. 2. An irregular degenerated subserosal myoma (M) of the uterus (Ut) was
shown during cesarean section after closure of the uterine incision.In dealing with a complex degenerated myoma, malignancy
should be considered before any decision regarding surgery is
made. The presence of central hypervascularity, a high peak
systolic velocity, or a low resistance index of tumor vessels on
Doppler analysis, and a high LDH serum value have been
collectively linked to a suspicion of uterine malignancy [10,11].
In conclusion, a very high CA 125 level in early pregnancy
may be associated with a degenerated subserosal myoma.
Subsequent CA 125 levels obtained after first trimester
together with color Doppler sonography may be helpful in
determining the origin of a pelvic mass in pregnancy.References
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